METTL3 and acute myeloid leukemia: Our prior investigation demonstrated that METTL3 expression is significantly decreased in AML BMMSCs in contrast to their healthy donor counterparts and that METTL3 mediates BMMSC adipogenesis to promote chemoresistance in human AML cell lines in vitro [25].